Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy BELLUS Health stock (BLU)

Buy BELLUS Health stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

BELLUS Health is a biotechnology business based in the US. BELLUS Health shares (BLU) are listed on the NASDAQ and all prices are listed in US Dollars. BELLUS Health employs 74 staff and has a trailing 12-month revenue of around $15,000.

Our top picks for where to buy BELLUS Health stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy BELLUS Health stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BLU. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy BELLUS Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

BELLUS Health stock price (NASDAQ: BLU)

Use our graph to track the performance of BLU stocks over time.

BELLUS Health shares at a glance

Information last updated 2023-08-27.
Latest market close$14.74
52-week range$0.00 - $0.00
50-day moving average $14.59
200-day moving average $10.22
Wall St. target price$16.06
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.73

Is it a good time to buy BELLUS Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BELLUS Health price performance over time

Historical closes compared with the close of $14.74 from 2023-07-06

1 week (2024-07-13) N/A
1 month (2024-06-20) N/A
3 months (2024-04-20) N/A
6 months (2024-01-20) N/A
1 year (2023-07-20) N/A
2 years (2022-07-22) 61.09%
3 years (2021-07-23) 426.43%
5 years (2019-07-24) 75.35%

BELLUS Health financials

Revenue TTM $15,000
Gross profit TTM $16,000
Return on assets TTM -16.7%
Return on equity TTM -26.76%
Profit margin 0%
Book value $2.91
Market Capitalization $1.9 billion

TTM: trailing 12 months

BELLUS Health share dividends

We're not expecting BELLUS Health to pay a dividend over the next 12 months.

Have BELLUS Health's shares ever split?

BELLUS Health's shares were split on a 1:3.6 basis on 18 August 2019. So if you had owned 3.6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BELLUS Health shares – just the quantity. However, indirectly, the new 260% higher share price could have impacted the market appetite for BELLUS Health shares which in turn could have impacted BELLUS Health's share price.

BELLUS Health share price volatility

Over the last 12 months, BELLUS Health's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BELLUS Health's is -0.279. This would suggest that BELLUS Health's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, BELLUS Health has bucked the trend.

BELLUS Health overview

BELLUS Health Inc. , a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Frequently asked questions

What percentage of BELLUS Health is owned by insiders or institutions?
Currently 10.261% of BELLUS Health shares are held by insiders and 90.409% by institutions.
How many people work for BELLUS Health?
Latest data suggests 74 work at BELLUS Health.
When does the fiscal year end for BELLUS Health?
BELLUS Health's fiscal year ends in December.
Where is BELLUS Health based?
BELLUS Health's address is: 275 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4A7
What is BELLUS Health's ISIN number?
BELLUS Health's international securities identification number is: CA07987C2040
What is BELLUS Health's CUSIP number?
BELLUS Health's Committee on Uniform Securities Identification Procedures number is: 07987C105

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site